Wealth Enhancement Advisory Services
HQL

Wealth Enhancement Advisory Services’s abrdn Life Sciences Investors HQL Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Sell
10,686
-1
-0% -$18 ﹤0.01% 3510
2026
Q1 		$180K Buy
+10,687
New +$179K ﹤0.01% 3170
2024
Q4 		– Sell
-15,932
Closed -$240K – 3030
2024
Q3 		$240K Sell
15,932
-3,851
-19% -$58.3K ﹤0.01% 2332
2024
Q2 		$280K Sell
19,783
-661
-3% -$8.94K ﹤0.01% 2030
2024
Q1 		$279K Buy
20,444
+991
+5% +$13.7K ﹤0.01% 1973
2023
Q4 		$262K Sell
19,453
-1,427
-7% -$17.6K ﹤0.01% 1907
2023
Q3 		$260K Buy
+20,880
New +$275K ﹤0.01% 1829

Other funds holding HQL

1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
PFO
PMG Family Office Plano, Texas $109M AUM 15.87% 1-Year Est. Return
DI
Decision Investments San Diego, California $110M AUM
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
LOPW
Live Oak Private Wealth Wilmington, North Carolina $800M AUM 24.59% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
SFS
Shaker Financial Services Arlington, Virginia $319M AUM 3.9% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Wealth Enhancement Advisory Services's HQL Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its abrdn Life Sciences Investors (HQL) stake by 0.01% in Q2 2026, selling an estimated $18 and leaving 10,686 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #3510.

Wealth Enhancement Advisory Services first reported a position in HQL in Q3 2023 and has held it in 7 quarters since. The position peaked at $280K in Q2 2024. 14 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Wealth Enhancement Advisory Services held 10,686 shares of abrdn Life Sciences Investors worth $217K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 1 abrdn Life Sciences Investors share in Q2 2026, an estimated $18.
  • abrdn Life Sciences Investors made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3510 holding.
  • Wealth Enhancement Advisory Services first reported a position in abrdn Life Sciences Investors in Q3 2023 and has held it in 7 quarters since.
  • Wealth Enhancement Advisory Services's abrdn Life Sciences Investors position peaked at $280K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.